Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats

Richard W Nelson, Randy C. Lynn, Colette C. Wagner-Mann, Gina M. Michels

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Objective - To evaluate effects of protamine zinc insulin (PZI) on control of glycemia in cats with newly diagnosed diabetes mellitus or poorly controlled diabetes. Design - Clinical trial. Animals - 67 diabetic cats. Procedure - 34 cats with newly diagnosed diabetes and 33 cats with poorly controlled diabetes were treated with PZI twice daily for 45 days. Control of glycemia was assessed on days 7, 14, 30, and 45 by evaluation of clinical response, change in body weight, serum fructosamine concentration, blood glucose concentration measured 1, 3, 5, 7, and 9 hours after administration of PZI, lowest blood glucose concentration, and mean blood glucose concentration during the 9-hour period after administration. Adjustments in dosage of PZI were made as needed to attain control of glycemia. Results - For all cats, a significant increase in mean dosage of PZI and significant decreases in 9-hour mean blood glucose concentration, lowest mean blood glucose concentration, and mean serum fructosamine concentration were detected. For cats with poorly controlled diabetes, 9-hour mean blood glucose concentration and mean serum fructosamine concentration were significantly decreased on day 45, compared with day 0. Ninety percent of owners reported improvement or resolution of clinical signs by day 45. Conclusions and Clinical Relevance - Results suggest that PZI was effective for control of glycemia in cats with newly diagnosed or poorly controlled diabetes and may be used as an initial treatment or as an alternative treatment in cats that do not respond to treatment with other types of insulin.

Original languageEnglish (US)
Pages (from-to)38-42
Number of pages5
JournalJournal of the American Veterinary Medical Association
Volume218
Issue number1
StatePublished - Jan 1 2001

Fingerprint

Isophane Insulin
protamines
diabetes mellitus
blood glucose
Diabetes Mellitus
Cats
insulin
zinc
cats
Blood Glucose
Fructosamine
diabetes
Serum
Body Weight Changes
body weight changes
dosage
Clinical Trials
Insulin
clinical trials

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats. / Nelson, Richard W; Lynn, Randy C.; Wagner-Mann, Colette C.; Michels, Gina M.

In: Journal of the American Veterinary Medical Association, Vol. 218, No. 1, 01.01.2001, p. 38-42.

Research output: Contribution to journalArticle

Nelson, Richard W ; Lynn, Randy C. ; Wagner-Mann, Colette C. ; Michels, Gina M. / Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats. In: Journal of the American Veterinary Medical Association. 2001 ; Vol. 218, No. 1. pp. 38-42.
@article{bfccaa1f776d45cbbf047e13e43e4b8c,
title = "Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats",
abstract = "Objective - To evaluate effects of protamine zinc insulin (PZI) on control of glycemia in cats with newly diagnosed diabetes mellitus or poorly controlled diabetes. Design - Clinical trial. Animals - 67 diabetic cats. Procedure - 34 cats with newly diagnosed diabetes and 33 cats with poorly controlled diabetes were treated with PZI twice daily for 45 days. Control of glycemia was assessed on days 7, 14, 30, and 45 by evaluation of clinical response, change in body weight, serum fructosamine concentration, blood glucose concentration measured 1, 3, 5, 7, and 9 hours after administration of PZI, lowest blood glucose concentration, and mean blood glucose concentration during the 9-hour period after administration. Adjustments in dosage of PZI were made as needed to attain control of glycemia. Results - For all cats, a significant increase in mean dosage of PZI and significant decreases in 9-hour mean blood glucose concentration, lowest mean blood glucose concentration, and mean serum fructosamine concentration were detected. For cats with poorly controlled diabetes, 9-hour mean blood glucose concentration and mean serum fructosamine concentration were significantly decreased on day 45, compared with day 0. Ninety percent of owners reported improvement or resolution of clinical signs by day 45. Conclusions and Clinical Relevance - Results suggest that PZI was effective for control of glycemia in cats with newly diagnosed or poorly controlled diabetes and may be used as an initial treatment or as an alternative treatment in cats that do not respond to treatment with other types of insulin.",
author = "Nelson, {Richard W} and Lynn, {Randy C.} and Wagner-Mann, {Colette C.} and Michels, {Gina M.}",
year = "2001",
month = "1",
day = "1",
language = "English (US)",
volume = "218",
pages = "38--42",
journal = "Journal of the American Veterinary Medical Association",
issn = "0003-1488",
publisher = "American Veterinary Medical Association",
number = "1",

}

TY - JOUR

T1 - Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats

AU - Nelson, Richard W

AU - Lynn, Randy C.

AU - Wagner-Mann, Colette C.

AU - Michels, Gina M.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Objective - To evaluate effects of protamine zinc insulin (PZI) on control of glycemia in cats with newly diagnosed diabetes mellitus or poorly controlled diabetes. Design - Clinical trial. Animals - 67 diabetic cats. Procedure - 34 cats with newly diagnosed diabetes and 33 cats with poorly controlled diabetes were treated with PZI twice daily for 45 days. Control of glycemia was assessed on days 7, 14, 30, and 45 by evaluation of clinical response, change in body weight, serum fructosamine concentration, blood glucose concentration measured 1, 3, 5, 7, and 9 hours after administration of PZI, lowest blood glucose concentration, and mean blood glucose concentration during the 9-hour period after administration. Adjustments in dosage of PZI were made as needed to attain control of glycemia. Results - For all cats, a significant increase in mean dosage of PZI and significant decreases in 9-hour mean blood glucose concentration, lowest mean blood glucose concentration, and mean serum fructosamine concentration were detected. For cats with poorly controlled diabetes, 9-hour mean blood glucose concentration and mean serum fructosamine concentration were significantly decreased on day 45, compared with day 0. Ninety percent of owners reported improvement or resolution of clinical signs by day 45. Conclusions and Clinical Relevance - Results suggest that PZI was effective for control of glycemia in cats with newly diagnosed or poorly controlled diabetes and may be used as an initial treatment or as an alternative treatment in cats that do not respond to treatment with other types of insulin.

AB - Objective - To evaluate effects of protamine zinc insulin (PZI) on control of glycemia in cats with newly diagnosed diabetes mellitus or poorly controlled diabetes. Design - Clinical trial. Animals - 67 diabetic cats. Procedure - 34 cats with newly diagnosed diabetes and 33 cats with poorly controlled diabetes were treated with PZI twice daily for 45 days. Control of glycemia was assessed on days 7, 14, 30, and 45 by evaluation of clinical response, change in body weight, serum fructosamine concentration, blood glucose concentration measured 1, 3, 5, 7, and 9 hours after administration of PZI, lowest blood glucose concentration, and mean blood glucose concentration during the 9-hour period after administration. Adjustments in dosage of PZI were made as needed to attain control of glycemia. Results - For all cats, a significant increase in mean dosage of PZI and significant decreases in 9-hour mean blood glucose concentration, lowest mean blood glucose concentration, and mean serum fructosamine concentration were detected. For cats with poorly controlled diabetes, 9-hour mean blood glucose concentration and mean serum fructosamine concentration were significantly decreased on day 45, compared with day 0. Ninety percent of owners reported improvement or resolution of clinical signs by day 45. Conclusions and Clinical Relevance - Results suggest that PZI was effective for control of glycemia in cats with newly diagnosed or poorly controlled diabetes and may be used as an initial treatment or as an alternative treatment in cats that do not respond to treatment with other types of insulin.

UR - http://www.scopus.com/inward/record.url?scp=0035179189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035179189&partnerID=8YFLogxK

M3 - Article

C2 - 11149712

AN - SCOPUS:0035179189

VL - 218

SP - 38

EP - 42

JO - Journal of the American Veterinary Medical Association

JF - Journal of the American Veterinary Medical Association

SN - 0003-1488

IS - 1

ER -